| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
15.090 |
Evidence |
|
| IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
15.090 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
15.090 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
15.090 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
15.090 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
15.090 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
15.090 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
15.090 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
15.090 |
Evidence |
|
| CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
15.090 |
Evidence |
O
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
THOP1 |
THOP1: Thimet oligopeptidase |
15.090 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
15.090 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
15.090 |
Evidence |
|
| KLK1 |
KLK1: Kallikrein-1 precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
15.080 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
15.080 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
GAB2 |
IPI00186990 |
15.080 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
TGFA |
TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow |
15.080 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
15.080 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
15.080 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
15.080 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
15.080 |
Evidence |
O
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SFTPA2 |
SFTPA2, PSAP, SFTP1, SFTPA: Pulmonary surfactant-associated protein A2 precursor |
15.080 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
SH3BP3 |
|
15.080 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
15.080 |
Evidence |
|
| MMP9 |
MMP9, CLG4B: Matrix metalloproteinase-9 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
15.080 |
Evidence |
|